Insect viruses have evolved strategies to control the host RNAi antiviral defense mechanism. In nature, Drosophila melanogaster C virus (DCV) infection causes low mortality and persistent infection, whereas the closely related cricket paralysis virus (CrPV) causes a lethal infection. We show that these viruses use different strategies to modulate the host RNAi defense machinery. The DCV RNAi suppressor (DCV-1A) binds to long double-stranded RNA and prevents processing by Dicer2. In contrast, the CrPV suppressor (CrPV-1A) interacts with the endonuclease Argonaute 2 (Ago2) and inhibits its activity without affecting the microRNA (miRNA)-Ago1-mediated silencing. We examined the link between viral RNAi suppressors and the outcome of infection using recombinant Sindbis viruses encoding either CrPV-1A or DCV-1A. Flies infected with Sindbis virus expressing CrPV-1A showed a marked increase in virus production, spread and mortality. In contrast, Sindbis pathogenesis was only modestly increased by expression of DCV- 1A. We conclude that RNAi suppressors function as virulence factors in insects and can target the Drosophila RNAi pathway at different points.
RNA interference (RNAi) is a highly conserved, post-transcriptional gene-expression control mechanism involved in a number of critical cellular processes 1 . In insects and plants, RNAi functions as a major antiviral defense mechanism 2 . In Drosophila, Dicer2, a class III double-stranded RNA (dsRNA) endonuclease, processes viral dsRNA structures into small interfering RNAs (siRNAs). siRNAs assemble into RNA-induced silencing complexes (RISCs) to serve as guides for the endonuclease Ago2, which targets the viral RNA for degradation. As a countermeasure to RNAi antiviral defense, viruses encode suppressors of RNA silencing (VSR) to modulate host antiviral response.
The study of viral RNAi suppressors has provided insights into the mechanistic details of siRNA and miRNA production as well as RISC assembly. A number of factors, including helicases, dsRNA-binding proteins and endonucleases, are required for the proper assembly of functional RISCs 3, 4 . Accordingly, viral suppressors can potentially target any of these factors to circumvent the host RNAi defense. Intriguingly, most RNAi suppressors are RNA-binding proteins that interact with dsRNA precursors and/or siRNAs to inhibit dsRNA processing by Dicer and assembly of RISC 5 . However, some plant viral RNAi suppressors also target components of the RNAi machinery itself. For instance, P0 suppressor protein of the plant polerovirus inhibits downstream events in RISC assembly by promoting Ago1 degradation [6] [7] [8] . Another plant virus RNAi suppressor, cucumber mosaic virus (CMV) 2b, inhibits both the siRNA and miRNA pathways by blocking Ago1 cleavage activity 9 . Furthermore, inhibition of RNA silencing by most plant viral suppressors also affects miRNA function, causing developmental abnormalities that may contribute to the pathogenic consequences of infection 9, 10 .
Several insect viruses also encode RNAi suppressors 2, 11 . Drosophila C virus (DCV) is a positive-strand RNA virus within the Dicistroviridae family that infects many strains of D. melanogaster and in nature establishes a nonlethal persistent infection [12] [13] [14] [15] [16] [17] . A closely related dicistrovirus, cricket paralysis virus (CrPV), however, produces lethal infections in field crickets 18 and fruit flies 19 . The viral RNA genomes are comprised of two distinct open reading frames, termed ORF1 and ORF2, and the expression of both is determined by internal ribosome entry site (IRES)-mediated translational initiation 20 . ORF1 encodes the nonstructural replication proteins, whereas ORF2 encodes the structural proteins that form the viral capsid. Experimental infection by DCV and CrPV is greatly exacerbated in flies with genetic defects abrogating the RNAi effector proteins Dicer2 and Ago2, indicating that RNAi is a bona fide antiviral defense mechanism in insects [21] [22] [23] . The different outcomes of DCV and CrPV infections in nature led us to examine whether these closely related viruses use distinct strategies to control the host antiviral response. We previously reported that DCV encodes a dsRNA-binding protein, DCV-1A, that suppresses RNA silencing by specifically blocking Dicer2 processing of virus dsRNA into siRNAs 22 . In contrast, the mechanism used by CrPV to counteract the Drosophila immune system has not been established.
Here we show that CrPV encodes a potent VSR, CrPV-1A, that interacts with Ago2 and inhibits RISC activity. Furthermore, unlike plant virus RNAi suppressors, this hitherto undescribed RNAi inhibitor neither affects the miRNA pathway nor alters the normal development A r t i c l e s and physiology of the animal. Given the distinct pathogenic outcomes observed in DCV and CrPV infections in nature, we hypothesized that RNAi suppressors may function as virulence factors. Indeed, we found that CrPV and DCV RNAi suppressors can modulate the outcome of Sindbis virus infection in flies. Recombinant Sindbis virus expressing CrPV-1A increased virus production, resulting in high mortality, whereas DCV-1A expression resulted in only a modest enhancement of infection. We propose that insect virus RNAi suppressors are key modulators of the host immune response, fine tuning the outcome of infection in line with the evolutionary viral strategy for successful host transmission, and that the suppressors target multiple components of the RNAi pathway in insects as in plants, including Argonaute.
RESULTS

CrPV infection blocks RNAi in S2 cells
Drosophila deficient in the key RNAi endonucleases Dicer2 and Ago2 are highly susceptible to CrPV infection, suggesting that the fly RNAi machinery plays an essential role in antiviral defense [21] [22] [23] . Therefore, we examined the possibility that CrPV may encode a suppressor of RNAi to control the RNA-silencing machinery. We analyzed RNAi suppression in S2 cells using a dual luciferase reporter system consisting of a firefly luciferase (FLuc)-expressing plasmid and a specific 200-nucleotide (nt) dsRNA targeting the firefly luciferase mRNA or an enhanced green fluorescent protein (eGFP) dsRNA control (Ctrl) 22 (Fig. 1a) . Drosophila S2 cells were either CrPV-or mock-infected for 24 h before co-transfection with the reporter system for RNAisilencing activity. We also included an internal control using Renilla reniformis luciferase (RLuc) in each experiment. In uninfected control cells, we observed efficient silencing of firefly luciferase (suppression by a factor of 380) as compared to a control dsRNA. In contrast, silencing was completely suppressed in CrPV infected cells ( Fig. 1a) , indicating that CrPV encodes a potent suppressor of RNAi.
CrPV ORF1 encodes an RNAi suppressor DCV and CrPV are closely related species within the Cripavirus genus of the Dicistroviridae family. Residue sequence alignment between DCV and CrPV indicated a high degree (~55%) of identity within ORF1. A dsRNA-binding motif (DSRM) was previously identified within the N-terminal 99-residue region of DCV ORF1, spanning residues 25-88, and was shown to encode a potent suppressor of RNAi (DCV-1A) 22 . Based on these observations, we set out to determine whether the suppression of RNAi by CrPV could be attributed to a DCV-1A-like RNAi suppressor that mapped to the N terminus of CrPV ORF1.
Alignment of DCV and CrPV in this region revealed no substantial homology compared to homologous downstream residue sequences, a group that includes a highly conserved octamer sequence DVEXNPGP (Fig. 1b) . This octamer sequence serves as a signal for co-translational protein cleavage between the glycine and proline residues in several picornaviruses 24 . We hypothesized that this DVEXNPGP sequence may have a similar function during DCV and CrPV polyprotein processing. We previously reported a DSRM within sequences upstream of the DVEXNPGP site that functions as a potent RNAi suppressor protein in DCV 22 . We detected a protein with a molecular weight consistent with cleavage at the DVEXNPGP site in CrPV-infected cells by western blot analysis using a polyclonal antibody raised against the first 148 N-terminal residues of CrPV ORF1 (Fig. 1c) .
Next, we evaluated the ability of the CrPV sequence upstream of the DVEXNPGP motif to suppress RNAi in S2 cells. Using the dualreporter assay, we co-transfected luciferase (Fluc and Rluc)-expression plasmids with dsRNA that specifically targets firefly luciferase and plasmids encoding C-terminal deletions of the putative CrPV RNAi suppressor protein (N-terminal 168, 148, 128 or 108 residues). Both CrPV-1A 168 and CrPV-1A 148 efficiently blocked RNA silencing ( Fig. 1d) . In contrast, CrPV-1A 128 and CrPV-1A 108 expression did not suppress RNAi (Fig. 1d) . Hence, the N-terminal 148 residues of CrPV ORF1 are sufficient to block RNAi in S2 cells. To examine the effects of CrPV-1A suppressor in vivo, we generated transgenic flies expressing the CrPV-1A 148 protein, the inactive CrPV-1A 108 fragment or GFP. To monitor the effects of the CrPV-1A 148 suppressor in vivo, we crossed transgenic flies with flies expressing a hairpin dsRNA (inverted repeat) targeting the white gene (IR[white]). The expression of two mini-white genes would be suppressed by expression of this hairpin dsRNA, thus providing a colorimetric readout for RNA silencing. A r t i c l e s GFP and the IR[white] hairpin, causing an orange eye color due to the loss of red eye pigmentation ( Fig. 2a) . In contrast, RNA silencing was suppressed in flies expressing CrPV-1A 148 , resulting in expression of the white gene and, thus, a red eye color. Flies expressing the inactive CrPV-1A 108 were able to suppress the white gene similarly to the GFP flies ( Fig. 2a) . Therefore, our observations show that CrPV-1A 148 is a potent RNAi suppressor in Drosophila.
To further characterize CrPV-1A 148 (herein named CrPV-1A) suppressor, we compared its RNAi-suppressing efficiency with that of the RNAi suppressor of DCV, DCV-1A 99 (herein named DCV-1A). We assessed suppression by CrPV-1A and DCV-1A in transgenic flies by measuring the accumulation of red eye pigments in flies expressing each of the RNAi suppressor proteins under the control of identical promoters ( Fig. 2a) . We defined the red eye pigment absorbance (OD 480 ) from control flies expressing GFP and IR[white] as 100% silencing, and we defined the OD 480 value from flies not expressing IR[white] ( Fig. 2a , 1A 148 , no IR [white] (−)) as the maximum inhibition of silencing. Flies expressing CrPV-1A and IR[white] inhibited RNA silencing (14% silencing) thus restored the red eye phenotype, whereas DCV-1A expression resulted in a modest effect on RNA silencing (50% silencing) ( Fig. 2a ; compare 1A 148 with DCV-1A). Control flies expressing CrPV-1A 108 or GFP showed maximum silencing induced by the dsRNA hairpin targeting white gene ( Fig. 2a) . Western blot analysis showed that each suppressor protein accumulated to similar levels ( Supplementary Fig. 1a ). Furthermore, the pathogenic effect of DCV infection was exacerbated by the expression of CrPV-1A, resulting in higher mortality compared to that of transgenic flies expressing DCV-1A ( Fig. 2b) . Together, these data indicate that CrPV-1A is a more potent RNAi suppressor than DCV-1A.
CrPV-1A inhibits siRNA function but not the miRNA pathway
In plants, many VSRs also interfere with the miRNA pathway and are often associated with disease symptoms resembling plant developmental defects 25 . Thus, we examined whether CrPV-1A also inhibits the Drosophila miRNA pathway. We carried out experiments in S2 cells using a firefly luciferase reporter containing two perfect complementary miR2b sequences (antisense) in its 3′ untranslated region (UTR) 22 (Supplementary Fig. 1b ). We used another firefly luciferase reporter containing two copies of the miR2b sequence in the opposite orientation (sense) as a control. We co-transfected S2 cells with firefly luciferase miR2b reporter constructs (sense or antisense), a plasmid encoding Renilla luciferase (transfection control) and constructs expressing either CrPV-1A or DCV-1A. The ratio of luciferase (miR2b antisense/miR2b sense) expression was identical in cells transfected with DCV-1A, CrPV-1A, empty vector or no-plasmid control ( Fig. 2c) . We determined the dynamic range of the miR2b reporter assay using antisense oligos (ASO) targeting endogenous miR2b miRNA. ASO reduced miR2b silencing effect up to 50% compared to nonspecific ASO control ( Fig. 2d) . We concluded that CrPV-1A does not affect the miRNA gene silencing pathway in S2 cells.
We further examined the effect of CrPV-1A on the miRNA pathway in third instar larvae. We crossed transgenic flies expressing CrPV-1A with transgenic flies containing a bantam miRNA sensor construct that allows in vivo imaging of bantam miRNA activity 26 . We expressed a GFP reporter containing three copies of a perfect bantam target sequence in its 3′ UTR under the control of the tubulin promoter ( Supplementary Fig. 1c ). Because bantam miRNA expression is temporally and spatially regulated in response to patterning cues, the expression of GFP in this case was under similar control, and we observed a characteristic GFP expression pattern in wing imaginal discs from transgenic larvae ( Fig. 2e , GFP/bantam). In contrast, a GFP transgene construct lacking the bantam target sequences showed ubiquitous GFP expression in wing imaginal discs ( Fig. 2e, GFP) . To monitor the effects of CrPV-1A on bantam, we used an engrailed-GAL4 driver to express CrPV-1A in the posterior compartment of the imaginal discs 27 . We observed no effect on bantam miRNA-mediated GFP repression in the presence of CrPV-1A ( Fig. 2e , GFP/bantam + CrPV-1A, and Supplementary Videos 1 and 2). Additionally, ubiquitous expression of CrPV-1A throughout development does not generate any defect in adult flies, further suggesting CrPV-1A does not affect the miRNA pathway in the intact animal (data not shown). Thus, unlike plant virus RNAi suppressors, CrPV-1A does not interfere with the host miRNA pathway. Recently a new class of small RNA called endogenous small interfering RNA (esiRNAs) has been described in Drosophila [28] [29] [30] . The esiRNAs derive from repetitive sequence elements such as retrotransposons and control their replication in somatic cells. To examine whether CrPV-1A perturbs the esiRNA pathway, we analyzed steadystate levels of three distinct retrotransposons, 297, mdg1 and 412 (refs. 28, 29) , in the heads of adult female transgenic flies expressing functional RNAi suppressor CrPV-1A 148 or DCV-1A 99 as well as those of control flies expressing nonfunctional suppressor CrPV-1A 108 or dsRNA binding mutant DCV-1A K73A (ref. 22 ). We used homozygous Ago2 414 mutant flies as positive control (Fig. 2f) . Expression of suppressor DCV-1A and CrPV-1A but not suppressor mutant controls substantially increased retrotransposon expression levels, indicating that the virus suppressors also inhibit the esiRNA pathway.
CrPV-1A blocks Ago2 cleavage activity
We next examined the mechanism by which CrPV-1A inhibits RNAi. Because most RNAi suppressors bind dsRNA to inhibit silencing 5 , we first determined whether CrPV-1A binds dsRNA. We performed electrophoretic mobility-shift experiments using radiolabeled dsRNA (200 base pairs (bp)) or siRNA (21 bp) probes and purified recombinant CrPV-1A or DCV-1A (Supplementary Fig. 2a ). Consistent with our previous findings 22 , DCV-1A efficiently bound long dsRNA ( Supplementary Fig. 2a, lane 1, left) and, to a lesser extent, siRNA ( Supplementary Fig. 2a, lane 1, right) . In contrast, CrPV-1A did not bind dsRNA or siRNA (Supplementary Fig. 2a, lanes 2-7 and 9-14 ). Next, we examined the effect of CrPV-1A on Dicer2 activity using an in vitro assay. In S2 cell extracts, dsRNA was efficiently processed to 21-bp siRNAs (Fig. 3a, lane 2) . Production of siRNA was inhibited by the addition of recombinant DCV-1A (Fig. 3a, lane 5) but not recombinant CrPV-1A or bovine serum albumin (BSA) control (Fig. 3a,  lanes 3 and 4) . These experiments indicated that CrPV-1A inhibits RNAi at a different step than does DCV-1A, functioning downstream of siRNA production. Indeed, CrPV-1A, unlike DCV-1A, effectively blocked silencing induced by transfection of both long dsRNA in S2 cells as well as 21-bp siRNA (Supplementary Fig. 2b) , supporting a role for CrPV-1A downstream of siRNA production. siRNAs produced by Dicer2 are incorporated into the RISC to guide mRNA cleavage. Three siRNA nucleoprotein (siRNP) complexes occurring during this assembly process can be resolved by native gel electrophoresis, including an initiator R1 (R2D2-Dcr2 initiator complex (RDI)), an intermediate R2 (RISC loading complex (RLC)) and an effector R3 (holo-RISC) complex [31] [32] [33] . We thus used native gel analysis to examine whether CrPV-1A affects RISC assembly. Incubation of radiolabeled siRNA duplex in Drosophila embryo extracts resulted in formation of the R1, R2 and R3 complexes (Fig. 3b,  lane 1) . The presence of CrPV-1A did not affect the assembly of these three complexes (Fig. 3b, lane 3) . In contrast, addition of DCV-1A inhibited formation of R3 (Fig. 3b, lane 2) , yielding two intermediate complexes (Fig. 3b, denoted by asterisk) . These experiments indicate that CrPV-1A does not affect siRNA loading or R3 assembly. Furthermore, we find that DCV-1A has a hitherto undescribed function affecting RISC assembly in addition to its previously described function of binding long dsRNA, suggesting that DCV-1A acts at several levels to inhibit RNAi function.
Next, we tested whether CrPV-1A affects RISC-mediated mRNA cleavage using an in vitro target-cleavage assay 34 (Fig. 3c) . We incubated S2 extracts, programmed with a FLuc siRNA or a nonspecific control siRNA, with a 592-nt radiolabeled cap FLuc mRNA substrate. In control reactions, the FLuc mRNA target was efficiently cleaved (5′ product) in the presence of a FLuc specific siRNA, as expected ( Fig. 3c; compare lane 3 with lanes 1 and 2) . Whereas addition of purified DCV-1A had little effect on target cleavage, FLuc mRNA cleavage was inhibited upon addition of purified recombinant CrPV-1A (Fig. 3c,  lanes 6, 7 and 8 for CrPV and lane 11 for DCV). Similarly, cleavage was also inhibited in extracts from CrPV-infected S2 cells (Fig. 3c, lanes  4 and 5) but not in DCV-infected S2 cells (Fig. 3c, lane 10) . These experiments show that CrPV-1A suppresses RNAi by inhibiting RISC activity without affecting Dicer processing or RISC assembly.
CrPV-1A interacts with Ago2
We hypothesized that CrPV-1A inhibits RISC activity by associating with one or more components of holo-RISC. To examine this possibility, we immunoisolated CrPV-1A carrying a C-terminal tandem A r t i c l e s affinity (Flag and histidine) purification tag (3FH-CrPV-1A) from S2 cells. Western blot analysis using Ago2-specific antibody revealed that CrPV-1A co-immunoprecipitated with Ago2 (Fig. 4a, lane 4, right) . In contrast, an antibody directed against Ago1 did not detect any Ago1 association with CrPV-1A (Fig. 4a. lane 2, left) , consistent with our results showing that CrPV-1A does not affect the Ago1-dependent miRNA pathway. The Ago2 antibody used detected two Ago2 forms of 130 kDa and 95 kDa. It is possible that the smaller form is the product of partial proteolysis during affinity-tag purification, as we often detect 95-kDa isoform (Fig. 4b,c) . To further analyze the interaction between CrPV-1A and Ago2, we transiently expressed 3FH-CrPV-1A 148 and 3FH-CrPV-1A 108 in S2 cells. Whereas full-length 3HF-CrPV-1A 148 co-precipitated with Ago2, the truncated CrPV-1A 108 was unable to interact with Ago2 (Fig. 4b, lane 2) . We further analyzed the interaction of CrPV-1A with Ago2 by two-step affinity purification from S2 extracts stably expressing 3FH-CrPV-1A 148 . Coomassie brilliant blue staining of the purified materials revealed the presence of only two distinct bands not present in the control sample ( Supplementary Fig. 3) ; MS analysis identified the two bands as CrPV-1A and Ago2. Furthermore, silver staining of CrPV-1Aassociated proteins uncovered no additional proteins (Fig. 4c, lane 2) . These experiments suggested that CrPV-1A blocks catalytic activity of the RISC by direct interaction with endonuclease Ago2.
CrPV-1A acts on preassembled holo-RISC
The observation that CrPV-1A does not affect siRNA-RISC assembly in vitro (Fig. 3b) , but nonetheless inhibits RISC cleavage activity (Fig. 3c) , suggests that CrPV-1A interferes with the function of assembled holo-RISC. To directly test this possibility, we performed a luciferase mRNA target-cleavage assay. We preincubated S2 cell extracts with duplex siRNA to allow holo-RISC assembly [31] [32] [33] , followed by recombinant CrPV-1A addition. CrPV-1A efficiently inhibited holo-RISC enzymatic activity even after assembly of holo-RISC (Fig. 5a, lane 3) . As expected, DCV-1A and BSA control had no effect on preassembled RISC cleavage (Fig. 5a, lanes 4 and 5) .
We also examined the ability of CrPV-1A to inhibit holo-RISC activity in vivo using the dual-luciferase reporter system in S2 cells expressing CrPV-1A under the control of an inducible metallothionein promoter (Fig. 5b) . We co-transfected cells with plasmids expressing Renilla and firefly luciferases and dsRNA targeting firefly luciferase (dsLuc) or GFP (dsGFP) for 16 h to allow for maximal silencing of luciferase activity (Fig. 5b, dsLuc) . Induction of CrPV-1A expression at 16 h resulted in near-complete restoration of firefly luciferase expression ( Fig. 5b , dsLuc + CrPV-1A) in contrast to the lack of expression of the CrPV-1A control (dsLuc). Together, these results indicate that CrPV-1A can efficiently inhibit preassembled holo-RISC function.
Previous findings have indicated that, in Drosophila, Ago2 is a component of active holo-RISC, which sediments with a ribosomal fraction following high-speed centrifugation (200,000g) (ref. 35) . To examine whether CrPV-1A associates with active holo-RISC, we subjected cytoplasmic extracts from S2 cells expressing 3FH-CrPV-1A to high-speed centrifugation to separate a high-molecular weight fraction (P200) from supernatant (S200) (Fig. 5c) . We analyzed fractions by immunoblotting using antibodies that specifically recognize Ago2 and CrPV-1A. Expression of CrPV-1A did not affect the distribution of Ago2 between the S200 and P200 fractions (Fig. 5d, α-Ago2 ). Furthermore, CrPV-1A expression did not affect siRNA association with the P200 fraction ( Fig. 5d, northern blot; compare lanes 1 and 2) . Notably, CrPV-1A fractionated preferentially with the high-molecular weight P200 fraction, despite the fact that purified recombinant CrPV-1A migrates as a smaller soluble protein in gel-filtration analysis (data not shown). We concluded that CrPV-1A neither induces Ago2 degradation nor causes disassembly of the holo-RISC; instead it is specifically recruited to the holo-RISC-containing P200 fraction, where it exerts an inhibitory effect through binding Ago2 (Fig. 5e) .
RNAi suppressors are virulence determinants
It is puzzling that two viruses with such overall homology as CrPV and DCV show markedly different virulence levels in natural infection 12, 13, 18, 19 . Both DCV and CrPV induce high mortality in fruit flies by intrathoracic injection in experimental laboratory condition 21, 22 . In contrast, DCV causes mild and persistent infection, whereas CrPV infection is highly lethal by oral inoculation 13, 14, 16, 19, 36, 37 . Furthermore, in S2 cells, DCV establishes a persistent infection following an initial acute phase, whereas CrPV is highly lytic, with no establishment of persistent infection (data not shown).
Virus pathogenesis is determined by many factors, including the ability of the virus to evade host immune response. Given the different properties of each suppressor, we considered whether they might determine the outcome of infection. Ideally, this hypothesis should be tested by engineering a virus carrying either of the different RNAi (Fig. 6a) . Control Sindbis viruses expressed inactive suppressors-a truncated version of CrPV-1A (Sin-CrPV 108 ) or DCV-1A carrying a mutation in the DSRM (Sin-DCV K73A) 22 . In addition to infecting insect cells, Sindbis also infects mammalian cells, which do not appear to use RNAi to control the virus, affording an unbiased control system for viral replication efficiency. We observed no appreciable differences in virus replication kinetics for these recombinant viruses in mammalian BHK-21 cells (Fig. 6b) , indicating that expression of RNAi suppressors does not affect virus fitness in cells where the RNAi machinery does not have a major role in antiviral defense 38 . Sindbis virus does not appear to encode an RNAi suppressor (data not shown) and establishes a persistent infection in Drosophila 39 . 
A r t i c l e s
We thus determined the effect of CrPV-1A and DCV-1A on Sindbis infection following intrathoracic inoculations in Drosophila. Both Sin-CrPV 148 and Sin-DCV 99 increased fly mortality compared to the control virus expressing an inactive suppressor, Sin-CrPV 108 (Fig. 6c) .
Consistent with the observation that CrPV-1A is a more effective RNAi suppressor than DCV-1A ( Fig. 2a,b) , Sin-CrPV 148 induced higher mortality in flies than did Sin-DCV 99 (Fig. 6c) . This enhanced pathogenicity correlated with a marked increase in virus replication (Fig. 6d , α-GFP and fluorescence AU). Notably, Sin-CrPV 148 infection generated a broader GFP tissue distribution as seen in the thorax, abdomen, head and legs of injected flies (Fig. 6d, i) . Infection with control Sin-CrPV 108 caused localized GFP expression at the site of injection, suggesting that the absence of a functional suppressor limits both infectivity (Fig. 6d , ii) and virus spread (Fig. 6d, i) . We measured a modest increase in GFP expression during Sin-DCV 99 infection that was localized predominately in the thorax and, to a lesser extent, in the head of injected flies (Fig. 6d, ii) . Quantification of GFP expression by western blotting and fluorescence microscopy showed that GFP expression was approximately five-fold higher in flies infected with Sin-CrPV 148 compared to Sin-DCV 99 (Fig. 6d , α-GFP and fluorescence AU). GFP expression steadily increased during the first 10 d after Sin-CrPV 148 infection, at which point GFP levels remained constant (data not shown). Notably, infected flies showed maximum GFP expression 10 d after Sin-DCV 99 infection, followed by a gradual reduction in fluorescence, suggesting that flies were able to control the infection.
We thus observed a striking correlation between the enhancement of Sindbis infection severity by CrPV-1A, the potency of this suppressor and the virulence of natural CrPV infections. In contrast, DCV, which produces a moderate natural infection, carries a suppressor that causes a modest increase in Sindbis virulence. Taken together, these results indicate that these distinctly acting RNAi suppressors are virulence factors that determine the outcome of infection.
DISCUSSION
RNAi can provide sequence specific antiviral immunity in plants and insects [40] [41] [42] . To counteract this antiviral mechanism, viruses have evolved suppressor proteins with RNAi-modulating activity. Here we identified a unique mode of action used by CrPV for suppressing RNAi-based antiviral immunity. This suppression activity mapped to the N-terminal region of CrPV ORF1, encoding the protein CrPV-1A. We find that CrPV-1A specifically interacts with Ago2 in the context of preassembled holo-RISC and can potently suppress RNAi in Drosophila. The mechanism used by CrPV-1A is different from that used by RNAi suppressors from flock house virus (B2) and DCV (1A), which appear to prevent viral dsRNA processing by Dicer 2 and siRNAs to assemble into RISC 2, 11 . This widely used strategy presumably relies on physical shielding of viral dsRNAs from the RNAi machinery. In contrast, CrPV-1A shows no detectable RNA-binding affinity (Supplementary Fig. 2) and does not prevent the loading of siRNAs ( Figs. 3b and 5d) or the formation of holo-RISC ( Figs. 3b and 5d) . We find that CrPV-1A interacts with Ago2 ( Fig. 4c) and inhibits RISC activity in vivo and in vitro without affecting Dicer processing or RISC assembly ( Figs. 3-5) . CrPV-1A, in the absence of other viral proteins, is preferentially recruited to high-molecular weight, preassembled holo-RISC fractions containing Ago2 and siRNAs ( Fig. 5d) and inhibits holo-RISC catalytic activity following RISC preformation and assembly (Fig. 5a) . In principle, additional CrPV-1A functions within the CrPV replication cycle cannot be excluded, given the multifunctional nature of many viral proteins. However, the fact that CrPV-1A alone both inhibits RNAi and suffices to enhance pathogenicity of the evolutionarily unrelated Sindbis virus shows that CrPV-1A is itself an RNAi suppressor with an autonomous pathogenesis-modulating function, which is transferable to other viruses.
Although the existence of virus-encoded RNAi suppressors in animals is now firmly documented, relatively little is known about how these factors intersect with host functions and how they contribute to the overall balance between viral replication and transmission. Comparison of RNAi-suppression strategies of two closely related viruses, DCV and CrPV, yields insights into both issues. Notably, we find that both viruses are specific for the host siRNA pathway, as neither CrPV-1A nor DCV-1A affected the miRNA gene-silencing pathway (Fig. 2) . Indeed, CrPV-1A suppresses the siRNA-mediated gene-silencing pathway by selectively interacting with Ago2 and not with the related Ago1 homolog (Fig. 4a) involved in miRNA-mediated RISC function. Both DCV and CrPV affect the esiRNA-mediated retrotransposon silencing by virtue of their ability to counteract the functions of Dicer2 and Ago2, respectively (Fig. 2f) . These observations contrast with those for known plant virus RNAi suppressors, which do not discriminate between the siRNA and miRNA pathways 9, 25, 43 . Because of aberrations in the miRNA pathway during infection, plant viruses often cause physiological and developmental abnormalities within the host 9, 25, 43 . The difference between plant and animal viruses may be explained by the interdependent nature of the plant siRNA and miRNA pathways as opposed to the distinctly separate pathways observed in Drosophila 3 . Because miRNAs are important for host physiology and development, the selectivity in RNAi suppression in insect viruses may afford them an evolutionary advantage. By controlling the host RNAi antiviral response without perturbing normal host physiology, viruses may replicate efficiently and establish a persistent infection as well as facilitating vertical transmission of the virus to the host progeny. These strategies would ensure virus transmission and survival within a host population.
DCV and CrPV are closely related viruses within the Dicistroviridae family. Although both viruses encode RNAi suppressor at N terminus of their genomes, these suppressors have very different mechanisms of action and RNAi-suppressor potencies. Our data suggest that their potency for inhibition of the host antiviral defense contributes to their different pathogenicities. Indeed, engineering Sindbis virus to carry DCV-1A and CrPV-1A altered the pathogenicity of an otherwise benign Sindbis infection in flies to an acute one of varying severity. Because we expressed both RNAi suppressors within the same site of the Sindbis virus, using the same promoter and in the absence of other CrPV or DCV proteins, these experiments provide a direct readout of the link between their autonomous RNAi-suppressor function and pathogenicity. The expression of the more potent RNAi suppressor, CrPV-1A, substantially enhanced Sindbis virus pathogenicity and correlated with a dramatic increase in virus replication and fly mortality. By contrast, Sin-DCV 99 was only moderately more pathogenic. It is tempting to speculate that the different potencies of the CrPV and DCV RNAi suppressors stem from their very different modes of action. DCV-1A relies on nonspecific RNA-binding activity to protect long dsRNA from Dicer2 processing; therefore, complete RNAi inhibition likely requires high levels of DCV-1A production to saturate all Dicer2 processing sites. In contrast, CrPV-1A acts by directly inhibiting the catalytic component of RISC (Fig. 5e) , a multiturnover enzyme 44 . Thus, inhibition of the siRISC by CrPV-1A may provide a more efficient strategy to prevent viral genome degradation, which may lead to high viral titer production.
The differential potency of the RNAi suppressors of DCV and CrPV and their different effects on Sindbis pathogenicity resonate with the different types of infection caused by these otherwise similar viruses. CrPV is a highly lytic virus that induces substantial mortality in flies 19 , whereas DCV, in nature, establishes a symbiotic, chronic infection in Drosophila without causing appreciable mortality 12, 13, 16, 45 . Indeed, DCV was first found in field populations by random screening of the flies and not as a result of any particular syndrome 13 . Given that the pathogenic characteristics of DCV and CrPV infection are replicated by simply transferring the respective RNAi suppressors to Sindbis virus, we argue that these proteins are attuned with the natural virus infection strategy. For instance, the chronic, persistent infection of Drosophila characterized by DCV may be attributed to the modest RNAi-suppressing activity shown by DCV-1A. Our results point to an exquisite equilibrium between the host antiviral defense machinery and the viral RNAi suppressors that serves as an evolutionary fine tuner of the host-virus interactions and determines the pathogenic outcome of infection, virus survival, and virus spread.
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